Singapore markets close in 3 hours 34 minutes

Aptevo Therapeutics Inc. (APVO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.9600+0.2493 (+35.08%)
At close: 04:00PM EDT
1.2291 +0.27 (+28.03%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
6,779
0
3,114
12,292
4,309
Operating expenses
Research development
17,751
17,107
17,882
18,994
17,852
Selling general and administrative
14,025
11,771
13,873
14,698
13,951
Total operating expenses
31,776
28,878
31,755
33,692
31,803
Operating income or loss
-24,997
-28,878
-28,641
-21,400
-27,494
Total other income/expenses net
30,577
10,228
35,655
-8,008
-3,429
Income before tax
5,580
-18,650
7,014
-29,408
-30,923
Income from continuing operations
5,580
-18,650
7,014
-29,408
-30,923
Net income
6,397
-17,411
8,027
-28,457
-17,750
Net income available to common shareholders
6,397
-17,411
8,027
-28,457
-17,750
Basic EPS
-2.23
-
69.08
-267.08
-230.12
Diluted EPS
-2.23
-
69.08
-267.08
-230.12
Basic average shares
8,092
-
115.916
106.544
77.066
Diluted average shares
8,093
-
115.975
106.544
77.066